The German-Danish project to establish a biobank for bone marrow stem cells will be funded by Interreg Germany-Danmark with 2.3 million euro.
Human Raw Material for Treatment and Research
“A human biomaterial database, short Biobank, is an infrastructure that allows to collect and store human body substances such as blood, urine, DNA, cell cultures, and tissues to provide these biomaterials for scientific and therapeutic purposes”, said Jens Habermann, M.D., Ph.D. , Head of the Laboratory for Surgical Research, Dept. of Surgery, University of Lübeck.
The Target: Recovery of Bone Marrow Stem Cells
The declared goal is the recovery of bone marrow stem cells as part of routine operations in the Danish and German trauma centres of Lübeck and Odense. Thus, a cross-border biobank for bone marrow stem cells has been officially started. “The BoneBank project paves the way for new stem cell therapies with versatile applications, for example in cancer or bone healing. In addition, our BoneBank provides an important innovation platform for novel medical products and therapies in regenerative medicine”, adds said Prof. Dr. Arndt Peter Schulz, M.R.C.S. (UK), Department of Surgery of UKSH and board member of the Life Science Nord
Many Partners in Northern Germany and Southern Denmark
Lead partner of the consortium is the Department of Surgery of the University Hospital Schleswig-Holstein (UKSH) at Lübeck in the Hamburg Metropolitan Region Together with the project partners Odense University Hospital, Stryker Trauma GmbH, soventec GmbH and Life Science North, the UKSH has been working on a comprehensive approach and project application last year. UKSH was supported in the project development by the Kiel-basedcompany DSN Connecting Knowledge.
“With its BoneBank, the consortium is pursuing an innovative way to make stem cells more readily available for research and therapy. At the same time, the project strengthens the co-operation between German and Danish companies, hospitals and research institutions,” said Dr. Hinrich Habeck, managing director of Life Science Nord GmbH.